Groupama Asset Managment Sells 6,877 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Groupama Asset Managment lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 134,964 shares of the healthcare conglomerate’s stock after selling 6,877 shares during the quarter. Groupama Asset Managment’s holdings in UnitedHealth Group were worth $68,535,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. NewSquare Capital LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at $25,000. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth about $30,000. Promus Capital LLC bought a new position in UnitedHealth Group during the 4th quarter valued at about $32,000. Pillar Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $40,000. Finally, DecisionPoint Financial LLC boosted its holdings in shares of UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after acquiring an additional 62 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 1.6 %

Shares of NYSE:UNH opened at $524.48 on Tuesday. The company has a 50 day moving average price of $509.10 and a two-hundred day moving average price of $543.47. The company has a market capitalization of $479.75 billion, a PE ratio of 33.84, a PEG ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the previous year, the company posted $5.83 earnings per share. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.33% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

UNH has been the subject of several research analyst reports. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Oppenheimer increased their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a report on Friday, January 10th. Finally, StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Twenty investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.